Testing the Efficacy of Mebendazole Induced Apoptosis in Pancreatic Cancer Cells
Overview
According to the American Society of Clinical Oncology (ASCO), Pancreatic Cancer is the fourth leading cause of cancer-related death and has a five-year survival rate of 8%.1 Previous research at John Hopkins and the National Institute of Health (NIH) has shown that Mebendazole2 has been an effective treatment for Brain3, Gastric4 and Colon5 Cancer. Research done last year, tested the effectiveness (measured by cell viability using trypan blue) of Mebendazole at a 1, 3, and 10µM dilutions on a Pancreatic Cancer Cell-line (ATCC UACC-462).6 The Pancreatic Cancer Cell-line is an epithelial tissue derived from the Peritoneal Metastases site, which is the primary site where the Pancreatic Cancer formed before spreading throughout the body. Peritoneal Metastases occurs in about 50% of Pancreatic Cancer patient at or before time of death according to the NIH.7 A healthy Pancreatic cell-line, obtained from Cell Biologics8, were also used to rule out any risk of contamination and to test the response of healthy Pancreatic cells when exposed to Mebendazole at the three concentrations. The study found that Mebendazole was effective at reducing cell viability significantly (P<0.05) at all three concentrations without greatly compromising the healthy Pancreatic cell-line. This year in partnership with Mote Marine Laboratory in Sarasota, Florida, the research will study the pathways of Apoptosis9, which is a programmed cell death that occurs in multicellular organisms.10 The research will use a caspase-3 assay11 to determine if Apoptosis is occurring in the Pancreatic Cancer Cell-line (ATCC UACC-462) causing the Pancreatic Cancer Cells to die off when exposed to Mebendazole at a 3µM dilution and measured using Cell Flow Cytometry methodology.12-16
Competition history
- AJAS 2019
Related projects
ISEF · 2014
Determining the Active Compound in Achyranthes aspera Leaf Extract and Its Effects on the Cell Cycle and Growth of Pancreatic Cancer Cells
ISEF · 2014
CARV-A-CURE: A Cell Viability Analysis of the Cancericidal Effects of Carvacrol on Pancreatic and Colorectal Carcinoma, Part Two
ISEF · 2022
Altering Metabolic Pathways To Override Drug Resistance in Cancer
ISEF · 2024
The Effect of UPP1, A Novel Metabolic Suppressor vs. Oncolytic Viruses on Pancreatic Cancers
ISEF · 2025
Investigating the Role of Nicotinamide Adenine Dinucleotide Precursors in Pancreatic Cancer Prevention
CSEF · 2008
The Effects of a Fatty Acid Synthase Inhibitor on Multi-drug Resistant Ovarian Cancer Cells
CSEF · 2012
MicroRNA: A New Way to Fight Pancreatic Cancer
ISEF · 2020
The Effects of Antioxidants on Mouse Osteoblastic Cancer Cells: Comparative Analysis of Effectiveness of Apoptosis
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science